drugset / Trial / NCT01572740

Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes

NCT01572740

Phase 3 Completed 257 enrolled Novo Nordisk A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is conducted in Asia. The purpose of the trial is to investigate the efficacy and safety of liraglutide in combination with insulin therapy compared to insulin alone in Japanese subjects with type 2 diabetes mellitus. Subjects will remain on their pre-trial insulin therapy.

Timeline

Start
2012-04-05
Primary completion
2012-11-01
Completion
2013-03-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 0.9 mg Subcutaneous
Background Insulin Protein / enzyme biologic